Hook Anatomy of Longevity & Supplement Brands
Supplement video ads classified frame by frame. What holds the frame at 00:00, how many seconds pass before the first claim, and how rarely anyone behind it cites an actual study.
Recharm Research · Edition 02 · September 2026
The category sells on science and almost never shows any.
Solid arc: no science reference of any kind. Light arc: vague science wording ("clinically studied", "backed by research"). Grey: a named study or institution.
A category that sells on evidence almost never presents any.
of ads make no science reference of any kind in the hook.
A further 5.8% use vague science wording, phrases such as "clinically studied" or "backed by research" with nothing attached. Only 7 ads, 0.8% of the sample, name a study, a journal or an institution.
The pattern repeats across every proof field measured. 98% show no quantified proof (no before-and-after, no review count, no biomarker). 89% never state how long results take. 15% carry a disclaimer. Taken together, 16% of ads carry any proof signal at all: a science reference, quantified proof, a stated timeframe, or a named study or institution.
"Any proof signal" counts an ad that has at least one of: a science reference (named or vague), quantified proof, a specific stated timeframe, or a named study or institution. Vague timeframe wording ("fast", "quickly", no period given) does not count as a stated timeframe on its own.
Almost every claim is a structure-function claim.
71% of ads open on a structure-function claim, the "supports energy" and "promotes gut health" register that stays inside FDA guidance. 14% make no claim in the hook at all. Ingredient or dosage claims lead 9%, comparison claims 3.7%, and social proof 2.3%. Only one ad in the sample was classified as an implied disease claim.
When a timeframe is stated, it is in weeks.
Only 11% of ads tell the viewer when to expect a result. Among them the most common window is one to four weeks (3.9% of all ads), followed by one to three months (3.1%). Under-a-week promises appear in 1.5% of ads, over-three-months in 0.8%, and a further 1.7% promise results in vague terms, "fast" or "quickly," with no period stated.
of the 81 ads fronted by a doctor or scientist cite no science
show an on-screen credential such as MD or PhD
The white coat is used as a costume. Fewer than half the doctors in the sample are credentialed on screen, and nine in ten do not reference a study.
Disclaimers split the category by brand, not by claim.
Disclaimer presence runs from 78% at Ritual and 66% at Pure Encapsulations down to 0% at LMNT and 0% at Momentous. By category, greens and foundational daily products carry one in 2 ads with a disclaimer; NAD+ and longevity, the category with the boldest promise, carries one in 17.
Recharm, The Hook Anatomy Report: Longevity & Supplements, Edition 02 (September 2026). Classification of 873 supplement video ads. 93% make no science reference in the hook; 0.8% name a study or institution; 98% show no quantified proof; 89% state no timeframe to result; 15% carry a disclaimer.
The default presenter isn't an expert. It's a customer who says it worked.
of ads are presented by an everyday customer giving a testimonial.
Unattributed actors and models present 14%, doctors and scientists 9.3%, athletes and trainers 7.1%, celebrities and influencers 5.2%, and founders 3.2%. 8.1% have no person present at all.
The customer testimonial outnumbers the expert presenter by 5.7 to one. And 89% of all ads carry no authority signal of any kind: no credential, no clinical setting, no team badge, no named institution.
Solo, face on camera, mostly female.
81% of ads show exactly one person in frame. 75% put the presenter's face on camera, speaking; 18% run voice-over with the presenter unseen; 5.7% show hands only. 56% of presenters read as female and 32% as male, but the split is set by category rather than by the industry: collagen and beauty is 91% female, multivitamins 88% female, and electrolytes 56% male.
of presenters are female
of presenters are male
carry no authority signal at all
Gender presentation is classified from what is visible on screen and describes casting, not the identity of any individual.
Recharm, The Hook Anatomy Report: Longevity & Supplements, Edition 02 (September 2026). Classification of 873 supplement video ads. 53% are presented by an everyday customer; 9.3% by a doctor or scientist; 89% carry no authority signal; 81% show a single person in frame.
One ad in three names no problem. When one is named, it is skin, gut or energy.
of ads state no concern at all in the hook.
Among the 585 ads that do name a problem, skin, hair and nails leads with 15%, followed by gut and digestion, energy and fatigue, and ageing and longevity. Ageing itself, the category's namesake, is the first concern in only 11% of ads that name one, and 7.4% of all ads.
Supplement routine burden, the "I was taking eleven pills a day" opening, is a concern in its own right at 10% of named problems. Sleep, stress, focus and immunity together account for just under 11% of named concerns; joint and mobility concerns add a further 0.9%, and hormone and libido concerns 0.3%.
Bars scaled against the largest concern. "Other" collects concerns too specific or too diffuse to fit the fixed list. Shares are of the 585 ads naming a concern, not of all ads. All fourteen concern values in the schema are shown above; none are omitted.
Each category has one problem, and protein has none.
Probiotic and gut ads name gut and digestion 60% of the time. Collagen and beauty ads name skin, hair and nails 73% of the time. NAD+ and longevity ads split between ageing (31%) and energy (18%). Protein and performance is the outlier: 52% of those ads open with no problem at all, the highest of any category.
The problem is spoken, almost never shown.
Among the 585 ads that name a concern, voice and text together carry it in 57%, voice alone in 35%, and on-screen text alone in 7.5%. Across the full sample of 873 ads, the concern is demonstrated visually, an actual tired face or a bloated stomach, in just 0.7%, six ads in total.
open with no problem stated
demonstrate the problem rather than say it
The category has a script for the problem and no footage of it. Text on screen is everywhere, and it is almost never used to name the concern.
Recharm, The Hook Anatomy Report: Longevity & Supplements, Edition 02 (September 2026). Classification of 873 supplement video ads. 33% state no concern in the hook. Among ads naming a concern, skin, hair and nails accounts for 15% and ageing and longevity for 11%. 0.7% demonstrate the concern visually.
Thirteen ways to open a supplement ad. Two of them carry nearly two thirds.
Every ad is classified by what holds the frame at 00:00, judged on the primary subject. All thirteen openings in the schema were observed. The two presenter-led openings take 63% between them.
A person addressing camera, no product yet.
A person and the product together at frame zero.
Running, cooking, working, living. No product.
The bottle, tub or pouch carries the frame.
The morning routine: kettle, counter, glass.
The capsule, gummy or scoop itself, not the pack.
Skin, hair, physique or a before-and-after.
A lab, a molecule, a mechanism diagram.
The pile of bottles the product replaces.
The mushroom, the berry, the raw compound.
Words on a plain ground before anything else.
Frames too ambiguous to classify.
A test result, a graph, a wearable readout.
Rounded to whole percentages, so the shares do not sum to exactly 100. Openings under 2.5% are shown to one decimal place.
The science is the rarest thing on screen.
Collapsed into families, the shape is blunt. A presenter holds frame zero in 63% of ads. B-roll of a life or a routine holds it in 20%. The product itself, in any form, holds it in 12%. An opening built on proof of any kind (a lab, a diagram, a biomarker, a body) holds it in 4.0%, and a science or data visual specifically in 1.6%.
Presenter-led: presenter to camera, presenter and product. B-roll-led: lifestyle or activity, routine or ritual. Product-led: product shot, supplement form, clutter or cabinet, ingredient. Proof-led: science or lab visual, data or biomarker screen, body or appearance shot, text-led claim card.
open on lifestyle or activity b-roll, the highest of any category
open on a presenter to camera with no product
open on a product shot
Recharm, The Hook Anatomy Report: Longevity & Supplements, Edition 02 (September 2026). Classification of 873 supplement video ads. 34% open on a presenter to camera and 29% on a presenter with product; 12% open product-led; 1.6% open on a science, lab, diagram or biomarker visual.
The product is on screen at 00:00. The claim lands at 00:05. The dose is rarely shown.
Four beats were timed in every ad where they occurred: the second the product first becomes visible, the second the supplement form (capsule, gummy, scoop) is first visible, the second the product is first consumed, and the second the first claim is stated. Bases differ because a beat that never happens has no time.
Median. 52% of ads that show the product show it at 00:00; 71% within three seconds. 77% of ads show it at all.
Median, in the 42% of ads that ever show the capsule, gummy, scoop or drop itself.
Median. 26% claim at 00:00, 53% within five seconds, 71% within ten.
Median, in the 24% of ads that show consumption. The shot itself lasts a median of 1.5s; 80% of consumption shots are two seconds or shorter.
The claim moves with the ad length.
In ads of 15 seconds or less the first claim lands at a median of 2.5 seconds. In 16-to-30-second ads it is 6 seconds, in 31-to-60-second ads 8 seconds, and in ads over a minute 20 seconds. The category's median ad runs 30 seconds; 23% run exactly 15 seconds, 21% exactly 30, 16% exactly 45 and 12% exactly 60. 92% are a minute or shorter.
Duration and length-band shares in this paragraph are quoted against the 657 ads where duration was captured, not all 873.
Bases: 121, 166, 238 and 51 ads respectively, limited to ads where both duration and first-claim time were captured.
Whether the dose is shown depends on what the dose is.
Electrolyte ads show consumption 56% of the time and greens 45%, because a drink being poured and drunk is the product demo. Protein sits at 34%. Probiotic and gut ads, where the dose is a capsule, show it 6% of the time. NAD+ and longevity, where the dose is increasingly a gummy, shows it 19%.
Recharm, The Hook Anatomy Report: Longevity & Supplements, Edition 02 (September 2026). Classification of 873 supplement video ads. Median time to first claim is 5 seconds; 26% make the first claim at 00:00. 24% show the product being consumed; the median consumption shot lasts 1.5 seconds. Median ad length is 30 seconds.
UGC and studio ads are two different grammars under one category label.
of ads are UGC selfie-style. 36% are studio-produced.
Mixed cuts make up 7.7%, podcast and interview clips 3.0%, and motion graphics 1.9%. The two main formats do not share a presenter, an opening, a setting or a pace.
UGC is a customer talking: 83% of UGC ads are fronted by an everyday customer. Studio is anyone but: 32% actor or model, 15% doctor or scientist, 14% athlete, 14% no person at all, and only 13% a customer.
Median first cut 1.8s · median first claim 5.75s
Median first cut 1.5s · median first claim 3.5s
The format is chosen by the category, not the brand.
Probiotics and multivitamins are UGC categories. Electrolytes are a studio category. NAD+ and longevity, the largest named category in the sample, is the only one split almost evenly. Any benchmark that averages the two describes an ad nobody is running.
| Category | UGC selfie-style | Studio-produced |
|---|---|---|
| Probiotic and gut109 ads | 77% | 13% |
| Multivitamin48 ads | 75% | 17% |
| Collagen and beauty88 ads | 67% | 17% |
| Other150 ads | 56% | 34% |
| Protein and performance146 ads | 48% | 36% |
| Greens and daily60 ads | 43% | 47% |
| NAD+ and longevity186 ads | 40% | 42% |
| Electrolyte and hydration68 ads | 15% | 81% |
Rows cover the eight categories meeting the 48-ad reporting threshold, 855 ads in total. "Other" is a residual bucket for ads that don't fit the fixed category list, kept in this table on the same footing as every other qualifying category rather than folded away. Functional mushroom and nootropic (15 ads) and hormone and men's health (3 ads) fall below the threshold and are the two categories excluded, matching the Method note. Rows do not sum to 100% within a category because mixed, podcast and motion-graphic formats are not shown.
The discount code lives in UGC.
91% of hooks carry no offer. Where one appears it is a discount or promo code (8.8% of all ads), and 79% of those promo hooks are UGC selfie-style. Probiotic and gut ads carry an offer in the hook 36% of the time, driven almost entirely by one brand; no other category exceeds 13%.
Kitchen, sofa, outdoors. Almost never the lab.
The kitchen holds 31% of openings, the living room or bedroom 20%, and outdoors 15%. The gym holds 7.8%, the bathroom 3.3%, and a plain studio backdrop 8.4%. A lab or clinical setting appears in 12 ads, 1.4% of the sample. 84% of ads carry text on screen, and the first cut lands at a median of 1.5 seconds: 32% cut within one second, 64% within two, 80% within three.
Recharm, The Hook Anatomy Report: Longevity & Supplements, Edition 02 (September 2026). Classification of 873 supplement video ads. 52% are UGC selfie-style and 36% studio-produced. 83% of UGC ads are presented by an everyday customer versus 13% of studio ads. 84% carry a text overlay; median first cut is 1.5 seconds; 1.4% open in a lab or clinical setting.
The combinations the category is leaving on the table.
Each of these is a move the schema can see, the category has the budget for, and fewer than one ad in fifty is making. None of them is exotic. Together they are the shortest list of ways for a supplement hook to look unlike the other 872.
Seven ads name the research. Every other science claim floats free.
A lab, a diagram or a biomarker at frame zero. Fourteen ads.
Quantified appearance proof in a category that sells appearance.
The pile of bottles at 00:00, while routine burden is 10% of named concerns.
The problem demonstrated on camera instead of narrated.
12 ads. The kitchen holds 31%.
23% compare to "other supplements". Almost none say which.
Electrolytes and nootropics could promise this. Almost none do.
A category this uniform means the same handful of moves are sitting open for any brand willing to use them. In a feed where 63% of hooks open on a person talking with no source behind the claim, a cited study, a lab bench, or a demonstrated symptom is a pattern interrupt on its own.
What this adds up to
Across 873 ads and 24 brands, the category keeps making the same choices: cast a customer, open on their face, make a structure-function claim within about five seconds, put text on screen, and never show the study, the dose or the source behind the claim. None of that is wrong. The testimonial format is common, likely because it converts well; the missing study may also partly reflect a compliance reflex, since citing a specific claim or study creates a substantiation obligation brands would rather avoid. But a formula this uniform is also a map of where a hook can stand out. The gap between what everyone does and what almost no one does is, in this category, the difference between a testimonial that says "it worked for me" and a claim that shows its source.
How this was measured.
Every figure comes from frame-level classification of individual video ads, rather than from survey responses, platform-reported metrics or manual review of a highlight reel.
The sample
873 video ads from 24 supplement and longevity advertisers: AG1, Ancient Nutrition, BiOptimizers, Bulletproof, Codeage, Cymbiotika, Goli Nutrition, LMNT, MaryRuth Organics, Momentous, Nature Made, Nutrafol, OLLY, Onnit, Pure Encapsulations, Renue By Science, Ritual, Seed, Thorne, Timeline, Transparent Labs, Tru Niagen, Vital Proteins and Wonderfeel. Ads were sourced from the Meta Ads Library and were running on Facebook, Instagram, Threads, Messenger and Audience Network; 95% began their flight in 2026, the remainder in 2025. The roster is weighted toward direct-to-consumer advertisers, where the category's video output has concentrated. Duplicate or near-identical cuts of the same ad were removed, so each ad in the sample is counted once.
Classification
Each ad was processed with Recharm's AI tagging system, which watches the asset frame by frame and assigns structured values against a fixed schema of 36 fields in eight sections. Every ad carries the same fields, so any two ads are directly comparable on any dimension. Classifications were checked by human reviewers before inclusion; ads flagged for review were retained only after resolution. Opening-frame classification carried a confidence rating, and 87% of ads were rated high confidence.
What was captured
Opening type and creative format; supplement category, delivery format, regimen framing, ingredient named first and offer in hook; presenter type, age band, gender presentation, people in frame, authority signal and ageing frame; the first concern raised and how it is delivered; first claim type, science reference, quantified proof, timeframe to result, competitor comparison and disclaimer; presenter presence, setting, text overlay and first cut time; and the proof clock: seconds to product visible, supplement form visible, consumption shown, first claim stated, and the duration of the consumption shot.
What counts as naming a concern
The first concern raised, spoken or written, in the first three seconds of the ad, is recorded against a fixed list of fourteen named concerns plus "Other" for anything specific that falls outside that list. Only the first concern is recorded, even where an ad raises more than one. Classification follows what is shown or said on screen, not what the brand's messaging implies without stating it. An ad that raises nothing identifiable in that window is recorded as "No concern stated," and that value, not an unclassifiable one, is what the 33% figure in section 03 reflects.
Reading the figures
Percentages are a share of all 873 ads unless stated otherwise, rounded to whole numbers; figures under 2.5% are shown to one decimal. Timing figures are medians across ads where the beat occurred and could be timed, and the base is stated alongside each. Ad duration was captured for 657 ads. Concern shares in section 03 are quoted against ads naming a concern. Category-level figures are reported for categories with 48 or more ads, which includes "Other," a residual bucket of 150 ads that don't fit the fixed category list; functional mushroom and nootropic (15 ads) and hormone and men's health (3 ads) fall below that threshold and are the only two excluded. Brand-level figures are reported for brands with 18 or more ads.
Reuse
Every chart, figure and infographic on this page is free to reproduce with attribution to Recharm and a link to this page. The suggested citation sits under each section.
Recharm Research · The Hook Anatomy Report: Longevity & Supplements · Edition 02
873 ads · 24 brands · 36 fields per ad · September 2026